Feb 09, 2026
https://www.benzinga.com/pressreleases/26/02/g50501462/kainova-therapeutics-secures-32m-cad-to-accelerate-development-of-immuno-oncology-and-inflammation?utm_campaign=channel&utm_content=taxonomy_rss&utm_medium=rss_feed_free&utm_source=benzinga_taxonomy
Turenne Capital Partners has invested $24M in Kainova Therapeutics Inc.